Page last updated: 2024-08-21

2,4-pyridinedicarboxylic acid and Kahler Disease

2,4-pyridinedicarboxylic acid has been researched along with Kahler Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Athanasou, N; Badock, V; Brennan, PE; Brown, J; Burgess-Brown, N; Egner, U; Gileadi, C; Hookway, ES; Johansson, C; Kopec, J; LaThangue, NB; Munro, S; Nowak, RP; Nuzzi, A; Oppermann, U; Philpott, M; Prinjha, R; Steuber, H; Strain-Damerell, C; Szykowska, A; Tumber, A; Velupillai, S; Westaway, S; Wu, N1

Other Studies

1 other study(ies) available for 2,4-pyridinedicarboxylic acid and Kahler Disease

ArticleYear
Structural analysis of human KDM5B guides histone demethylase inhibitor development.
    Nature chemical biology, 2016, Volume: 12, Issue:7

    Topics: Antineoplastic Agents; Cell Proliferation; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Histone Demethylases; Humans; Jumonji Domain-Containing Histone Demethylases; Models, Molecular; Multiple Myeloma; Nuclear Proteins; Protein Conformation; Repressor Proteins; Structure-Activity Relationship

2016